Key result
Sorin Bicarbon valve replacement is linked to ~4% 30-day mortality and low late mortality.
Observational (n=587)
The Sorin Bicarbon bileaflet prosthesis demonstrates excellent mid-term survival and low complication rates up to 9.8 years post-implantation.
No takes yet. Share an insight, caveat, or question.
Supports mid-term outcomes with Sorin Bicarbon valve in a single cohort; leaves open randomized comparisons to contemporary prostheses.
Spiliopoulos et al. (2008) conducted an observational in Heart valve replacement (n=587). Sorin Bicarbon bileaflet prosthesis was evaluated on Overall hospital mortality (30 days). Heart valve replacement with the Sorin Bicarbon prosthesis resulted in an overall 30-day hospital mortality of 4.2% and a late mortality of 1.98% per patient-year over up to 9.8 years.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: